C. Truffot-Pernot

发表

Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in Mice

N. Lounis, Abdelhalim Bentoucha, C. Truffot-Pernot, 2001, Antimicrobial Agents and Chemotherapy.

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

Hinrich W. H. Göhlmann, Philip Timmerman, Jean-Marc Neefs, 2005, Science.

In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosis

N. Lounis, C. Truffot-Pernot, B. Ji, 1998, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.

C. Truffot-Pernot, B. Ji, J. Grosset, 1991, Tubercle.

Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis.

K. Feldmann, S. Rüsch-Gerdes, C. Truffot-Pernot, 2000, The American journal of tropical medicine and hygiene.

Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis

K. Andries, V. Jarlier, N. Veziris, 2006, Antimicrobial Agents and Chemotherapy.

Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy

N. Lounis, C. Truffot-Pernot, B. Ji, 1992, Antimicrobial Agents and Chemotherapy.

Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France.

B. Dautzenberg, P. Diot, C. Truffot-Pernot, 1995, Chest.

Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients

B. Dautzenberg, J. Pellegrin, C. Truffot-Pernot, 1996, Antimicrobial agents and chemotherapy.

Mycobacterial lung disease in cystic fibrosis: a prospective study.

A. Clément, C. Truffot-Pernot, B. Fauroux, 1997, The Pediatric infectious disease journal.

Antibiotic Susceptibility Pattern ofMycobacterium marinum

S. Escolano, V. Jarlier, C. Truffot-Pernot, 2000, Antimicrobial Agents and Chemotherapy.

A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.

K. Andries, V. Jarlier, N. Veziris, 2009, American journal of respiratory and critical care medicine.

Efficient Intermittent Rifapentine-Moxifloxacin-Containing Short-Course Regimen for Treatment of Tuberculosis in Mice

V. Jarlier, N. Veziris, N. Lounis, 2005, Antimicrobial Agents and Chemotherapy.

Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.

G. Hejblum, N. Lounis, C. Truffot-Pernot, 2000, American journal of respiratory and critical care medicine.

Clarithromycin is inactive against Mycobacterium tuberculosis

N. Lounis, C. Truffot-Pernot, B. Ji, 1995, Antimicrobial agents and chemotherapy.

Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex

C. Truffot-Pernot, B. Ji, J. Grosset, 1991, Antimicrobial Agents and Chemotherapy.

Multiple cerebral abscesses as a complication of Mycobacterium fortuitum infection.

A. Laquérriere, V. Jarlier, C. Truffot-Pernot, 2003, European journal of internal medicine.

Efficacies of Clarithromycin Regimens against Mycobacterium xenopi in Mice

J. Robert, N. Lounis, Abdelhalim Bentoucha, 2001, Antimicrobial Agents and Chemotherapy.

Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1992, Antimicrobial Agents and Chemotherapy.

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1991, Antimicrobial Agents and Chemotherapy.

Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group.

J. Robert, C. Truffot-Pernot, J. Grosset, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A randomized comparison of two clarithromycin doses for treatment ofMycobacterium avium complex infections

B. Dautzenberg, C. Chastang, C. Truffot-Pernot, 1997, Infection.

Clarithromycin intheTreatment of Mycobacterium aviumLungInfections in Patients Without AIDS

B. Dautzenberg, P. Diot, C. Truffot-Pernot, 2015 .

Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1995, Antimicrobial agents and chemotherapy.

Hip Prosthesis Infection Due to Mycobacterium wolinskyi

J. Mainardi, I. Podglajen, W. Sougakoff, 2006, Journal of Clinical Microbiology.

Impacts of interleukin-12 on multiplication of Mycobacterium tuberculosis and Mycobacterium avium complex in mice.

N. Lounis, C. Truffot-Pernot, B. Ji, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model

N. Lounis, C. Truffot-Pernot, B. Ji, 1995, Antimicrobial agents and chemotherapy.

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1990, Antimicrobial Agents and Chemotherapy.

Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model

N. Lounis, C. Truffot-Pernot, B. Ji, 1994, Antimicrobial Agents and Chemotherapy.

Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.

K. Andries, V. Jarlier, N. Veziris, 2009, American journal of respiratory and critical care medicine.

Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment Duration

K. Andries, V. Jarlier, N. Veziris, 2006, Antimicrobial Agents and Chemotherapy.

An intervention programme for the management of multidrug-resistant tuberculosis in France.

B. Dautzenberg, V. Jarlier, J. Robert, 2007, International journal of antimicrobial agents.

How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?

N. Lounis, C. Truffot-Pernot, B. Ji, 1996, Antimicrobial agents and chemotherapy.

Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance

V. Jarlier, F. Brossier, W. Sougakoff, 2006, Journal of Clinical Microbiology.

Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002.

B. Dautzenberg, V. Jarlier, W. Sougakoff, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Characterization of New Mutations in Pyrazinamide-Resistant Strains of Mycobacterium tuberculosisand Identification of Conserved Regions Important for the Catalytic Activity of the Pyrazinamidase PncA

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 1999, Antimicrobial Agents and Chemotherapy.

Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 1994, The Journal of infectious diseases.

Multidrug-resistant tuberculosis: eight years of surveillance in France

V. Jarlier, J. Robert, C. Truffot-Pernot, 2003, European Respiratory Journal.

Mycobacterial Growth Indicator Tube Versus the Proportion Method on Löwenstein-Jensen Medium for Antibiotic Susceptibility Testing of Mycobacterium tuberculosis

V. Jarlier, C. Truffot-Pernot, J. Grosset, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.

P. Olliaro, C. Truffot-Pernot, B. Ji, 1993, The American review of respiratory disease.

Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice

C. Truffot-Pernot, B. Ji, J. Grosset, 1993, Antimicrobial Agents and Chemotherapy.

Fluoroquinolone-Containing Third-Line Regimen against Mycobacterium tuberculosis In Vivo

V. Jarlier, N. Veziris, N. Lounis, 2003, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

N. Lounis, C. Truffot-Pernot, B. Ji, 1995, Antimicrobial agents and chemotherapy.

Antibiotic Susceptibility Pattern of Mycobacterium marinum

S. Escolano, V. Jarlier, C. Truffot-Pernot, 2000 .

Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.

N. Lounis, C. Truffot-Pernot, J. Grosset, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.

C. Truffot-Pernot, J. Grosset, H. Lecoeur, 1989, The American review of respiratory disease.

Iron and Mycobacterium tuberculosis infection.

V. Gordeuk, N. Lounis, C. Truffot-Pernot, 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Tuberculosis caused by Mycobacterium africanum associated with involvement of the upper and lower respiratory tract, skin, and mucosa.

E. Caumes, C. Truffot-Pernot, J. Grosset, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1992, Antimicrobial Agents and Chemotherapy.

Chloroquine does not enhance the activity of clarithromycin against multiplication of Mycobacterium avium within human macrophages.

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments.

C. Truffot-Pernot, B. Ji, J. Grosset, 1991, Tubercle.

Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris.

V. Jarlier, C. Bernard, F. Brossier, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995–2004

V. Jarlier, J. Robert, C. Truffot-Pernot, 2007, European Respiratory Journal.

Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers.

V. Jarlier, W. Sougakoff, C. Truffot-Pernot, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

First isolation of Mycobacterium microti (Llama-type) from a dog.

G Hewinson, J. Thibaud, S. Blot, 2004, Veterinary microbiology.

MYCOBACTERIUM SZULGAI INFECTION IN A CAPTIVE POPULATION OF AFRICAN CLAWED FROGS (XENOPUS TROPICALIS)

B. Demeneix, W. Sougakoff, C. Truffot-Pernot, 2006, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

C. Truffot-Pernot, B. Ji, J. Grosset, 1992, Antimicrobial Agents and Chemotherapy.

Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?

N. Lounis, C. Truffot-Pernot, B. Ji, 1997, Antimicrobial agents and chemotherapy.

[Bacteriological tests for tuberculosis].

N. Veziris, C. Truffot-Pernot, 2011, Revue des maladies respiratoires.

A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.

V. Jarlier, J. Robert, C. Truffot-Pernot, 1999, The International Journal of Tuberculosis and Lung Disease.

[Mycobacterium fortuitum skin infection occurring after a facelift].

J. Ortonne, J. Roujeau, F. Mantoux, 2004, Annales de dermatologie et de venereologie.

Disseminated Infection with a Mycobacterium Related to Mycobacterium triplex with Central Nervous System Involvement Associated with AIDS

C. Katlama, B. Stankoff, W. Sougakoff, 2003, Journal of Clinical Microbiology.

Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis

V. Jarlier, F. Brossier, W. Sougakoff, 2010, Antimicrobial Agents and Chemotherapy.

TUBERCULOUS MENINGITIS DUE TO BCG IN TWO PREVIOUSLY HEALTHY CHILDREN

M. Tardieu, P. Landrieu, C. Truffot-Pernot, 1988, The Lancet.

Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis: Functional Analysis of Mutant Enzymes

V. Jarlier, N. Veziris, C. Truffot-Pernot, 2006, Antimicrobial Agents and Chemotherapy.

Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice.

C. Truffot-Pernot, B. Ji, R. O'brien, 1994, American journal of respiratory and critical care medicine.

Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.

N. Lounis, C. Truffot-Pernot, B. Ji, 1998, American journal of respiratory and critical care medicine.

Erratum: Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice (American Journal of Respiratory and Critical Care Medicine (1993) 148 (1541-1546))

P. Olliaro, C. Truffot-Pernot, B. Ji, 1994 .

Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice

N. Lounis, C. Truffot-Pernot, B. Ji, 1997, Antimicrobial agents and chemotherapy.

Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study

B. Heym, S. T. Cole, W. Jacobs, 1994, The Lancet.

[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].

C. Truffot-Pernot, J. Grosset, H. Lecoeur, 1983, Revue francaise des maladies respiratoires.

Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of Mycobacterium tuberculosis Resistant to Fluoroquinolones

V. Jarlier, N. Veziris, C. Truffot-Pernot, 2006, Antimicrobial Agents and Chemotherapy.

Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.

P. Lagrange, C. Truffot-Pernot, J. Grosset, 1989, Clinical and experimental immunology.

Mycobacterium avium Complex Common-Source or Cross-Infection in AIDS Patients Attending the Same Day-Care Facility

C. Katlama, V. Jarlier, C. Truffot-Pernot, 1998, Infection Control & Hospital Epidemiology.

Evaluation of the New MB Redox System for Detection of Growth of Mycobacteria

V. Jarlier, C. Truffot-Pernot, E. Cambau, 1999, Journal of Clinical Microbiology.

[Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].

C. Truffot-Pernot, J. Grosset, L. Maury, 1988, Revue des maladies respiratoires.

Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.

V. Jarlier, C. Truffot-Pernot, J. Grosset, 1995, The Journal of antimicrobial chemotherapy.

Identification of Mycobacterial Species by PCR Sequencing of Quinolone Resistance-Determining Regions of DNA Gyrase Genes

J. Dauendorffer, V. Jarlier, W. Sougakoff, 2003, Journal of Clinical Microbiology.

O477 Evaluation of a new version of the “RT-TB” triplex real-time PCR assay for the rapid diagnosis of Mycobacterium tuberculosis in clinical samples

V. Jarlier, F. Brossier, W. Sougakoff, 2007 .